- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 04:27 | AUSTRALIAN CLINICAL LABS LIMITED: Notification of cessation of securities - ACL | 1 | ASX | ||
| So | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| Do | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| Mi | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| Di | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 16.03. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 16.03. | AUSTRALIAN CLINICAL LABS LIMITED: Change in substantial holding | 1 | ASX | ||
| AUSTRALIAN CLINICAL LABS Aktie jetzt für 0€ handeln | |||||
| 11.03. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 11.03. | AUSTRALIAN CLINICAL LABS LIMITED: Notification of cessation of securities - ACL | 1 | ASX | ||
| 11.03. | AUSTRALIAN CLINICAL LABS LIMITED: Becoming a substantial holder from MQG | 1 | ASX | ||
| 11.03. | AUSTRALIAN CLINICAL LABS LIMITED: Becoming a substantial holder | 2 | ASX | ||
| 10.03. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 09.03. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 09.03. | AUSTRALIAN CLINICAL LABS LIMITED: Ceasing to be a substantial holder from MQG | 1 | ASX | ||
| 05.03. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 05.03. | AUSTRALIAN CLINICAL LABS LIMITED: Notification of cessation of securities - ACL | 3 | ASX | ||
| 04.03. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 03.03. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 02.03. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX | ||
| 01.03. | AUSTRALIAN CLINICAL LABS LIMITED: Update - Notification of buy-back - ACL | - | ASX |
1 2 3 4 5 Weiter >>
103 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CARL ZEISS MEDITEC | 23,660 | +0,34 % | BERNSTEIN RESEARCH stuft CARL ZEISS MEDITEC AG auf 'Neutral' | NEW YORK (dpa-AFX Analyser) - Das US-Analysehaus Bernstein Research hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 28,50 Euro auf "Market-Perform" belassen. Die europäische Medizintechnikbranche... ► Artikel lesen | |
| ECKERT & ZIEGLER | 14,520 | +2,83 % | EQS-PVR: Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Eckert & Ziegler SE
Eckert & Ziegler SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective... ► Artikel lesen | |
| MEDTRONIC | 74,60 | -0,17 % | Medtronic Wins FDA Approval For Expanded Use Of OmniaSecure Defibrillation Lead | WASHINGTON (dpa-AFX) - Medtronic plc (MDT) said Monday it has received approval from the U.S. Food and Drug Administration for an expanded indication of its OmniaSecure defibrillation lead.The... ► Artikel lesen | |
| STRATEC | 19,240 | +1,69 % | EQS-PVR: STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: STRATEC SE
STRATEC SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| M1 KLINIKEN | 14,220 | -2,07 % | M1 Kliniken schließt Verkauf von Haemato Pharm ab | Die M1 Kliniken AG hat den Verkauf der Haemato Pharm GmbH über ihre Mehrheitsbeteiligung Haemato AG an die Phoenix Group mit Wirkung zum Ablauf des 31. Januar 2026 abgeschlossen. Sämtliche Vollzugsbedingungen... ► Artikel lesen | |
| ZIMMER BIOMET | 76,48 | +0,76 % | Zimmer Biomet stock rating cut to neutral by BTIG on growth concerns | ||
| RYMAN HEALTHCARE | 1,070 | -3,08 % | RYMAN HEALTHCARE LIMITED: Amendments to Bond Trust Deed | ||
| SONIC HEALTHCARE | 11,806 | -2,22 % | Dividendenbekanntmachungen (04.03.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ASPIAL LIFESTYLE LIMITED SG2E90982678 0,008 SGD 0,0053 EUR AUTOLIV INC US0528001094 0,87 USD 0,7491 EUR AVERY DENNISON CORP US0536111091 0... ► Artikel lesen | |
| AMBU | 9,080 | +1,45 % | Ambu A/S: Interim Report For Q1 2025/26 | 4.2.2026 07:04:05 CET | Ambu A/S |
Interim report (Q1 and Q3)
Ambu had a solid start to the 2025/26 financial year, reflected by continued strong growth momentum. Endoscopy Solutions grew by 14.4%... ► Artikel lesen | |
| TRANSMEDICS GROUP | 101,10 | +2,56 % | TransMedics Group, Inc.: TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results | ANDOVER, Mass., Feb. 24, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant... ► Artikel lesen | |
| CVS | 13,600 | 0,00 % | Dividendenbekanntmachungen (06.11.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AIRTEL AFRICA PLC GB00BKDRYJ47 0,0216 GBP 0,0245 EUR ARMSTRONG WORLD INDUSTRIES INC US04247X1028 0,339 USD 0,2949 EUR ASHMORE GROUP... ► Artikel lesen | |
| EMBLA MEDICAL | 3,520 | 0,00 % | EMBLA MEDICAL HF: Transactions in relation to Share Buyback Program | ||
| EUROEYES | - | - | EUROEYES (01846): DATE OF BOARD MEETING | ||
| HEALIUS | 0,336 | 0,00 % | HEALIUS LIMITED: Change of Director's Interest Notice - Kathy Ostin | ||
| FRESENIUS MEDICAL CARE | 37,880 | -1,02 % | EQS-CMS: Fresenius Medical Care AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Fresenius Medical Care AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b) der Verordnung (EU) Nr. 596/2014
Fresenius Medical Care AG: Veröffentlichung... ► Artikel lesen |
Das Unternehmen AUSTRALIAN CLINICAL LABS LIMITED kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu AUSTRALIAN CLINICAL LABS LIMITED finden Sie auf Wallstreet Online.